Showing 110 of 110on this page. Filters & sort apply to loaded results; URL updates for sharing.110 of 110 on this page
Products | BioSyent
BioSyent signs distribution pact for two CV products - BioTuesdays
Biosyent Inc (RX) Stock Price & News - Google Finance
BioSyent named to 2024 TSX Venture Top 50 - YouTube
BioSyent (TSX-V: RX) Presentation | Rivemont MicroCap Cocktail Event ...
BioSyent Inc. 2025 Q3 - Results - Earnings Call Presentation (TSXV:RX ...
BioSyent inviting you to PANP CE Sunday conference pharmacists and ...
Investors | BioSyent
BioSyent Inc. (TSXV:RX) | 2024 TSX Venture 50™ - YouTube
MicroCapClub Invitational: BioSyent (RX.V) | PDF
BioSyent Inc. Reports Strong Q1 2025 Results Amidst Global Market ...
BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on ...
BioSyent Inc. - AnnualReports.com
BioSyent
BioSyent Discusses 2023 Financial Performance, Product Launch and 2024 ...
BioSyent Inc. Financial Disclosures & Filings — TradingView
BioSyent Launches Inofolic® for Women with Polycystic Ovary Syndrome ...
BioSyent Inc | LinkedIn
About BioSyent | BioSyent
Biosyent.docx - Biosyent 1 Organization design and Characteristics ...
BioSyent to acquire Oral Science - BioTuesdays
BioSyent to Acquire Oral Science Inc.
BioSyent - FeraMAX Pd Maintenance 45 Iron Supplement for Prevention of ...
BioSyent Inc - Corporate Communications at BioSyent | LinkedIn
BIOSYNTH logo - Abyntek Biopharma
BioSyent Discusses Q4 and FY 2024 Results, Tibelia Acquisition and 2025 ...
BioSyent (TSX.V: RX) Update with CEO Rene Goehrum - YouTube
Contact | BioSyent
BioSyent Inc. (TSX-V: RX) Webcast | Planet MicroCap Showcase: VIRTUAL ...
MicroCapClub Invitational: BioSyent (RX.V)
BioSyent (BIOYF / RX) Company Webcast - Lytham Partners Corporate ...
Your Stock Our Take BioSyent Inc. (RX:TSX-V) - YouTube
BIOSYENT INC. Aktie (A1J6DY | CA0906901081) • onvista
BioSyent CEO to Present Growth Strategy at LD Micro Conference | BIOYF ...
BioSyent Announces Launch of New FeraMAX® Pd Maintenance 45
BioSyent Inc. to acquire Oral Science Inc. in $25.5M deal - Oral Health ...
Biosyent Announces Q2 and H1 2025 Financial Results - Pharma ...
Discover how BioSyent Inc. captures fast physician insights – at a ...
BioSyent (TSXV:RX) Stock Price & Overview
BioSyent In-Licenses Endocrinology Product for Canada | Maulik Patel
RX Investor Relations - Biosyent Inc - Alpha Spread
Biosyent Q2 & H1 2025 Financial Results Released - Pharmavanguard ...
BioSyent Brands | LinkedIn
Biosyntia logo | Center for Antibody Technologies
Biosyent Inc - WKN A1J6DY, ISIN CA0906901081 | DivvyDiary
Pharmaceutical Sales Representative - BioSyent - Winnipeg | Isarta Jobs
Biosyent – GOLDFARMACI
Biosyent Announces Launch of New FeraMAX® Pd Therapeutic 150
BioSyent Announcing New Financial Results For Q3 And YTD - Pharma ...
Benefits of Hyaluronic Acid | Repagyn®
The Duffer 2019 - The Duffer 2019 - St. Michael's Hospital Foundation
Myo-inositol and folic acid supplement for PCOS support.
BioSyent_AR_2018_cover - Swerve Design
Coupons
Companies - Lytham Partners Corporate Access Portal
【即時新聞】北美生技製藥廠BioSyent宣布季度股息調升10%至0.055加元 | CMoney投資網誌
Contact| International Business | Biosint Asia Private Limited Singapore
BioSyent's 2024 Annual Report Design - Swerve Design
BioSynth™ | Dna research, Research logo, Tech image
Why Does BioSyent's Presentation Design Highlight Product Innovation ...
Annual Report Design, Toronto. Swerve Design Group Inc.
BioSyent_AR_2016 - Swerve Design
FAX Capital Files Early Warning Report Regarding Disposition of Common ...
Opening of Biosynth Biological Technology; a new Cutting-Edge Facility ...
Iron Supplement for the Treatment Of Iron Deficiency Anemia | FeraMAX®
